INHIBRX BIOSCIENCES INC (INBX) Institutional Ownership Changes & 13F Activity
INHIBRX BIOSCIENCES INC (INBX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Bank Of America Corp, Schonfeld Strategic Advisors Llc, Viking Global Investors, Parkman Healthcare Partners Llc, and Goldman Sachs Group Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -22 | -0.5% | 4,206 | $398.52K | Q2 2026 | Sep 09, 2026 |
| Corient Private Wealth Llc | Sell | -161 | -0.6% | 28,653 | $2.71M | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +7,256 | +1477.8% | 7,747 | $734.03K | Q2 2026 | Aug 24, 2026 |
| Ratan Capital Management Lp | Buy | +16,612 | — | 16,612 | $1.57M | Q2 2026 | Aug 18, 2026 |
| Fulcrum Asset Management Llp | Buy | +818 | — | 818 | $78.12K | Q2 2026 | Aug 18, 2026 |
| Jefferies Financial Group Inc. | Buy | +34,443 | +88.4% | 73,416 | $6.96M | Q2 2026 | Aug 17, 2026 |
| Bank Of America Corp | Buy | +808,458 | +2473.6% | 841,141 | $79.70M | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +442,759 | +173.7% | 697,586 | $66.10M | Q2 2026 | Aug 14, 2026 |
| Viking Global Investors | Sell | -313,776 | -21.8% | 1,123,929 | $106.49M | Q2 2026 | Aug 14, 2026 |
| Parkman Healthcare Partners Llc | Buy | +256,950 | — | 256,950 | $24.35M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +243,102 | +255.7% | 338,176 | $32.04M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -180,660 | -55.1% | 147,200 | $13.95M | Q2 2026 | Aug 14, 2026 |
| First Turn Management, Llc | Buy | +164,783 | — | 164,783 | $15.61M | Q2 2026 | Aug 14, 2026 |
| Perceptive Advisors Llc | Sell | -144,944 | -10.0% | 1,297,763 | $122.96M | Q2 2026 | Aug 14, 2026 |
| Summittx Capital, L.P. | Sell | -122,570 | -88.9% | 15,251 | $1.45M | Q2 2026 | Aug 14, 2026 |
| Sofinnova Investments, Inc. | Sell | -102,926 | -25.3% | 303,103 | $28.72M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -80,601 | -82.4% | 17,272 | $1.64M | Q2 2026 | Aug 14, 2026 |
| Eventide Asset Management, Llc | Buy | +61,545 | — | 61,545 | $5.83M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Sell | -55,115 | -71.2% | 22,322 | $2.12M | Q2 2026 | Aug 14, 2026 |
| Voloridge Investment Management, Llc | Buy | +35,264 | +261.2% | 48,765 | $4.62M | Q2 2026 | Aug 14, 2026 |
| Empyrean Capital Partners, Lp | Buy | +30,000 | — | 30,000 | $2.84M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +26,011 | — | 26,011 | $2.46M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Sell | -25,368 | -81.9% | 5,612 | $531.74K | Q2 2026 | Aug 14, 2026 |
| Nicholas Investment Partners, Lp | Buy | +21,443 | — | 21,443 | $2.03M | Q2 2026 | Aug 14, 2026 |
| Opaleye Management Inc. | Buy | +20,291 | — | 20,291 | $1.92M | Q2 2026 | Aug 14, 2026 |
| Voleon Capital Management Lp | Buy | +19,053 | +48.5% | 58,358 | $5.53M | Q2 2026 | Aug 14, 2026 |
| Verition Fund Management Llc | Buy | +17,993 | — | 17,993 | $1.70M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +16,858 | — | 16,858 | $1.60M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +16,459 | +4.3% | 400,892 | $37.98M | Q2 2026 | Aug 14, 2026 |
| Cdc Financial, Inc. | Buy | +15,600 | +12.5% | 140,130 | $13.28M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about INBX activity
Which institutional owners are buying INBX?
Institutional owners buying INBX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in INBX activity?
"Buy" means an investor increased their reported position in INBX compared to the prior reporting period. This reflects growing exposure to INHIBRX BIOSCIENCES INC (INBX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in INBX increasing?
Institutional interest in INBX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related INBX Institutional Insights
- INBX Overview
- INBX 13F Institutional Holders
- INBX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- INBX Insider Trading & SEC Form 4 Activity
- INBX Articles
- Top Institutional Investor Stock Rankings